ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2014

Dec 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2014-12-02

Reporting Person: O'Brien Patrick (General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-02	Common Stock	A	30000	—	Acquired	30000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-02	Stock Options	$5.22	A	90000	Acquired	2024-12-02	Common Stock (90000)	Direct

Footnotes

F1: Represents shares underlying restricted stock units, which shares will vest in three equal annual installments beginning on the anniversary of the grant date.

F2: Option vests and becomes exercisable over a four year period from date of grant.